DCGI panel clears Covaxin use for emergency use in kids as young as 2 years old

Current GK ( Master) Health and Diseases

Previously, the Drug Controller General of India had approved Zydus Cadila’s ZyCoV-D for emergency use in people aged 12 and above
The subject expert committee of the national drug regulator on Tuesday cleared Covaxin Covid shot for emergency use in children aged two to 18 years giving India the first approved vaccine for use in kids as small as two.
Previously, the Drug Controller General of India had approved Zydus Cadila’s ZyCoV-D for emergency use in people aged 12 and above.
The clearance to Covaxin for children between two to 18 comes at a time when schools are reopening with challenges in respect of protection of children from disease mounting. Although there is no clear evidence of children being more vulnerable to a potential third wave of the virus, countries have been expanding vaccination drives to cover children.
Covaxin is a collaboration between ICMR and Bharat Biotech.